Stoke Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2019 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Stoke Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2019 to Q2 2024.
  • Stoke Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2024 was 52.6M shares, a 19% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 52.6M +8.39M +19% Jul 31, 2024 10-Q 2024-08-07
Q1 2024 46.3M +2.12M +4.79% Mar 15, 2024 10-K 2024-03-25
Q3 2023 44.7M +5.22M +13.2% Oct 30, 2023 10-Q 2023-11-07
Q2 2023 44.3M +4.84M +12.3% Jul 31, 2023 10-Q 2023-08-07
Q1 2023 44.2M +6.83M +18.3% Apr 26, 2023 10-Q 2023-05-04
Q3 2022 39.4M +2.64M +7.18% Oct 31, 2022 10-Q 2022-11-14
Q2 2022 39.4M +2.67M +7.27% Jul 31, 2022 10-Q 2022-08-08
Q1 2022 37.4M +695K +1.9% Mar 1, 2022 10-K 2022-03-10
Q3 2021 36.8M +3.32M +9.92% Nov 1, 2021 10-Q 2021-11-08
Q2 2021 36.7M +3.51M +10.6% Aug 3, 2021 10-Q 2021-08-10
Q1 2021 36.7M +3.72M +11.3% Mar 1, 2021 10-K 2021-03-09
Q3 2020 33.5M +740K +2.26% Nov 5, 2020 10-Q 2020-11-12
Q2 2020 33.2M +523K +1.6% Aug 4, 2020 10-Q 2020-08-10
Q1 2020 32.9M Mar 16, 2020 10-K 2020-03-23
Q3 2019 32.7M Nov 12, 2019 10-Q 2019-11-12
Q2 2019 32.7M Aug 14, 2019 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.